Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources

BMC Public Health

Vladimir Kaplan²  Sima Djalali²  Barbara M Holzer³  Matthias Bopp³  Ueli Zellweger¹ 

[1] Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, Zürich CH-8001, Switzerland;Members of the FIRE Study Group, c/o Institute of General Practice, University of Zurich, Zurich, Switzerland;Center of Competence Multimorbidity, University of Zurich, Zurich, Switzerland

关键词: Obesity;    Dyslipidemia;    Diabetes mellitus;    Hypertension;    Population;    Prevalence;    Chronic medical condition;   

Others  :  1123000
DOI  :  10.1186/1471-2458-14-1157

 received in 2014-03-21, accepted in 2014-10-22,  发布年份 2014

【 摘 要 】

Background

Prevalence estimates of chronic medical conditions and their multiples (multimorbidity) in the general population are scarce and often rather speculative in Switzerland. Using complementary data sources, we assessed estimates validity of population-based prevalence rates of four common chronic medical conditions with high impact on cardiovascular health (diabetes mellitus, hypertension, dyslipidemia, obesity).

Methods

We restricted our analyses to patients 15-94 years old living in the German speaking part of Switzerland. Data sources were: Swiss Health Survey (SHS, 2007, n = 13,580); Family Medicine ICPC Research using Electronic Medical Record Database (FIRE, 2010-12, n = 99,441); and hospital discharge statistics (MEDSTAT, 2009-10, n = 883,936). We defined chronic medical conditions based on use of drugs, diagnoses, and measurements.

Results

After a careful harmonization of the definitions, a high degree of concordance, especially regarding the age- and gender-specific distribution patterns, was found for diabetes mellitus (defined as drug use or diagnosis in SHS, drug use or diagnosis or blood glucose measurement in FIRE, and ICD-10 codes E10-14 as secondary diagnosis in MEDSTAT) and for hypertension (defined as drug use alone in SHS and FIRE, and ICD-10 codes I10-15 or I67.4 as secondary diagnosis in MEDSTAT). A lesser degree of concordance was found for dyslipidemia (defined as drug use alone in SHS and FIRE, and ICD-10 code E78 in MEDSTAT), and for obesity (defined as BMI ≥ 30 kg/m2 derived from self-reported height and weight in SHS, from measured height and weight or diagnosis of obesity in FIRE, and ICD-10 code E66 as secondary diagnosis in MEDSTAT). MEDSTAT performed well for clearly defined diagnoses (diabetes, hypertension), but underrepresented systematically more symptomatic conditions (dyslipidemia, obesity).

Conclusion

Complementary data sources can provide different prevalence estimates of chronic medical conditions in the general population. However, common age and sex patterns indicate that a careful harmonization of the definition of each chronic medical condition permits a high degree of concordance.

【 授权许可】

   
2014 Zellweger et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA: Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998, 51(5):367-375.
• [2]Wu SY, Green A: Projection of Chronic Illness Prevalence and Costs Inflation. Santa Monica: RAND Health; 2000.
• [3]Rizza A, Kaplan V, Senn O, Rosemann T, Bhend H, Tandjung R: Age- and gender-related prevalence of multimorbidity in primary care: the swiss fire project. BMC Fam Prac 2012, 13(1):113. BioMed Central Full Text
• [4]Bopp M, Zellweger U, Faeh D: Routine data sources challenge international diabetes Federation extrapolations of national diabetes prevalence in Switzerland. Diabetes Care 2011, 34(11):2387-2389.
• [5]Fortin M, Hudon C, Haggerty J, Akker M, Almirall J: Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res 2010, 10:111. BioMed Central Full Text
• [6]Chmiel C, Bhend H, Senn O, Zoller M, Rosemann T: The FIRE project: a milestone for research in primary care in Switzerland. Swiss Med Wkly 2011, 140:w13142.
• [7]Becker HW OS, Okkes IM, Van Boven K, Lamberts H: ICPC2-ICD10 Thesaurus. A diagnostic terminology for semi-automatic double coding in Electronic Patient Records. Academic Medical Center/University of Amsterdam Department of Family Medicine. In Academic Medical Center/University of Amsterdam, Department of Family Medicine, 2005 Edited by ICPC in the Amsterdam Transition Project CD-Rom Amsterdam, Okkes IM, Oskam SK, Lamberts H. 2005.
• [8]Esteban-Vasallo MD, Dominguez-Berjon MF, Astray-Mochales J, Genova-Maleras R, Perez-Sania A, Sanchez-Perruca L, Aguilera-Guzman M, Gonzalez-Sanz FJ: Epidemiological usefulness of population-based electronic clinical records in primary care: estimation of the prevalence of chronic diseases. Fam Prac 2009, 26(6):445-454.
• [9]Violan C, Foguet-Boreu Q, Hermosilla-Perez E, Valderas JM, Bolibar B, Fabregas-Escurriola M, Brugulat-Guiteras P, Munoz-Perez MA: Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity. BMC Public Health 2013, 13:251. BioMed Central Full Text
• [10]Barber J, Muller S, Whitehurst T, Hay E: Measuring morbidity: self-report or health care records? Fam Prac 2010, 27(1):25-30.
• [11]van den Bussche H, Schafer I, Wiese B, Dahlhaus A, Fuchs A, Gensichen J, Hofels S, Hansen H, Leicht H, Koller D, Luppa M, Nützel A, Werle J, Scherer M, Wegscheider K, Glaeske G, Schön G: A comparative study demonstrated that prevalence figures on multimorbidity require cautious interpretation when drawn from a single database. J Clin Epidemiol 2013, 66(2):209-217.
• [12]Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R, Ventriglia G, Caputi AP: Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Publ Health Med 2003, 25(3):254-257.
• [13]Muggah E, Graves E, Bennett C, Manuel DG: Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report. BMC Public Health 2013, 13:16. BioMed Central Full Text
• [14]Stringhini S, Tabak AG, Akbaraly TN, Sabia S, Shipley MJ, Marmot MG, Brunner EJ, Batty GD, Bovet P, Kivimaki M: Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 2012, 345:e5452.
• [15]Morabia A, Costanza MC: The obesity epidemic as harbinger of a metabolic disorder epidemic: trends in overweight, hypercholesterolemia, and diabetes treatment in Geneva, Switzerland, 1993-2003. Am J Publ Health 2005, 95(4):632-635.
• [16]Stringhini S, Spencer B, Marques-Vidal P, Waeber G, Vollenweider P, Paccaud F, Bovet P: Age and gender differences in the social patterning of cardiovascular risk factors in Switzerland: the CoLaus study. PloS One 2012, 7(11):e49443.
• [17]Huber CA, Szucs TD, Rapold R, Reich O: Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 2013, 13:1030. BioMed Central Full Text
• [18]Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemi MJ: Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health 2013, 13:15. BioMed Central Full Text